A patient in his 70s with presumed Parkinson's disease was evaluated by a neuropsychologist. This clinician diagnosed probable dementia with Lewy bodies, rather than true Parkinson's disease. What is ...
Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced plans to advance development of ...
Late-onset depression may be an early sign of Parkinson’s disease (PD) or Lewy Body dementia (LBD), according to a December study published in General Psychiatry. The study examined data from the ...
(RTTNews) - CervoMed Inc. (CRVO) has announced positive 32-week data from the Extension phase of its phase IIb RewinD-LB trial of oral investigational drug Neflamapimod for the treatment of dementia ...
Belfast Live on MSN
'I was diagnosed with Parkinson’s and dementia the same day but still have a positive outlook on life'
Her ‘onwards and upwards’ attitude is certainly helping her to still live life to the full.
CervoMed Inc. has announced that it will present at the 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders in Vienna, Austria, from April 1-5, 2025.
A team of researchers found there is a possible molecular connection between air pollution and an increased risk of developing Lewy body dementia. The study builds on a decade of research linking ...
New research suggests that depression in later life may be more than an emotional response to illness—it could be an early sign of serious brain disease. A new nationwide study published in General ...
Expert opinion from Alex T. Thomas MD · 40 years of experience · USA In general, the lifespan of patients diagnosed with LBD varies from about 5 to 8 years. Patients die from multiple complications ...
Welcome to Neurotransmissions, a new First Opinion column on the revolution in dementia. This is the second in a three-part series on the dramatically changing world of dementia. Read the first part ...
Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results